Utility of the Determination of New Biomarkers in the Urine of Dogs with Renal Disease
World Small Animal Veterinary Association World Congress Proceedings, 2015
L. Navarro; M.T. Verde; M. Pardo; S. Villanueva; C. Ferreira
Animal Medicine, University of Zaragoza, Zaragoza, Spain

Introduction

There are few markers in urine able to detect the renal damage or the earlier kidney failure. New molecules have been recently investigated in human and veterinary medicine.

Objective

The aim of the present study was to evaluate the utility of the determination in urine of three new markers, cystatin C (CysC), beta-2-microglobulin (B2M) and retinol-binding protein (RBP), in the diagnosis of renal disease in dogs.

Methods

A total of 59 dogs were included and classified in groups depending on the pathology: CKD (20), urinary tract pathologies other than CKD (18) and systemic diseases (21). Twenty healthy dogs were the control population.

New markers were determinate in urine with a particle-enhanced turbidimetric or nephelometric immune-assay (PETIA or PENIA). The concentrations were related to urinary creatinine, and results were correlated with traditional markers and compared between groups.

Results

A low sensitivity was found in the assay of new markers in the urine samples collected.

RBP were the best detected, especially in the group of dogs with CKD. The average of urinary retinol-binding protein-to-creatinine ratio (uRBP/c) and urinary cystatin C-to-creatinine ratio (uCys C/c) were higher in dogs with CKD than in normal dogs, but did not show significant difference. Only uRBP/c was correlated with traditional markers in dogs with evidence of renal damage.

Conclusion

Determination of urinary RBP by PENIA seems to be a promising, specific and early method in the diagnosis of canine renal disease. Additional studies with more number of animals are necessary to conclude this affirmation.

  

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

L. Navarro
Animal Medicine
University of Zaragoza
Zaragoza, Spain


MAIN : Critical Care & Emergency Medicine : Urine Biomarkers for Renal Disease
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27